Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorParc Sanitari Pere Virgili

About this trial

The goal of this clinical trial is to learn if a multi-professional (conducted by geriatricians, clinical pharmacists, nurses) medication revision, centered on patients' goals and characteristics, can improve treatment adequacy in older adults admitted to an intermediate care hospital.

The main question it aims to answer is: does this approach reduce the average number of medications taken per patient?

Researchers will compare this multi-professional patient-centered revision to the usual standard of care (treatment revision conducted by a clinical pharmacist) to see if the patient-centered revision works in improving treatment adequacy.

Participants admitted to an intermediate care hospital will undergo a comprehensive assessment by a geriatrician, and a medication revision (conducted by a multidisciplinary team or a clinical-pharmacist alone). They will also be asked to fulfill some questionnaires on their health status and attitudes. Any possible adverse events to the medications will be recorded at discharge. Participants will be contacted again three months after discharge to check for any readmission or death.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

older adults (65+ years)

≥ 3 or more chronic conditions requiring medical therapy

able to speak Spanish

capacity to provide informed consent or have a surrogate able to consent on their behalf

Disqualifiers

unable to provide informed consent

anticipated length of hospital stay < 72h

estimated life expectancy < 3 months

homeless

Trial design

Design model

Parallel

Treatments tested in this trial

  • Patient-centered multidisciplinary treatment review

    Other intervention

    Patient-centered multidisciplinary treatment review is defined as a medication review conducted by a multidisciplinary team (geriatrician, clinical pharmacist, nurse) according to a patient-centered methodology, based on person-centered evaluation of both personal and clinical insights, diagnostic-centered evaluation (based on current guidelines), and drug-centered evaluation (based on adequacy)

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: Control (usual care)No intervention 0 interventions
Group B: Intervention (patient-centered medication review)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of drugs

Median number of drugs per patient

Time frame
Baseline and after discharge, an average of 30 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.